Unknown

Dataset Information

0

Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.

ABSTRACT:

SUBMITTER: Eapen M 

PROVIDER: S-EPMC10947844 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Genomics Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children with Severe Sickle Cell Disease (BMT CTN-0601-BioLINCC)
| PRJNA1036724 | ENA
Genomics Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children with Severe Sickle Cell Disease (BMT CTN-0601-BioLINCC)
| PRJNA1036725 | ENA
Unknown Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.
| S-EPMC6511327 | biostudies-literature
Unknown Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.
| S-EPMC12779121 | biostudies-literature
Unknown Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.
| S-EPMC7819761 | biostudies-literature
Unknown Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101.
| S-EPMC10353308 | biostudies-literature
Unknown Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease.
| S-EPMC7448594 | biostudies-literature
Unknown Mismatched unrelated donor transplantation.
| S-EPMC5101019 | biostudies-literature
Unknown Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease.
| S-EPMC11635641 | biostudies-literature
Unknown Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.
| S-EPMC5699445 | biostudies-literature